vaginal microbiota
Professor Jacques Ravel, from University of Maryland School of Medicine and LUCA Biologics, discusses his latest research and therapeutic innovations in the field of vaginal microbiome modulation.
By addressing biases and increasing diversity in microbiota studies, researchers can develop more accurate and inclusive health strategies for women of different backgrounds.
Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.
Understanding the vaginal microbiome is essential not only for treating gynecological conditions but also for preventing them and promoting overall well-being.
A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.
A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).
A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.
Franco Vicariotto, Ospedale S. Pio X, Milan, talks about the results from a clinical trial in post-menopausal women.
The product, based on the pioneering research of Dr. Jacques Ravel, is the first of its kind to be clinically validated for establishing an optimal vaginal microbiome, dominated by Lactobacillus…
The findings of a recent study suggest that in bacterial vaginosis, certain vaginal microbes disrupt the protective glycans on vaginal epithelial cells, altering processes that mediate cell turnover, death and…
